Prevail Therapeutics Inc. Uncategorized Contracts & Agreements
9 Contracts & Agreements
- Form of Contingent Value Right Agreement, by and among Eli Lilly and Company, Tyto Acquisition Corporation and a rights agent mutually agreeable to Eli Lilly and Company and... (Filed With SEC on December 15, 2020)
- Tender and Support Agreement, dated December 14, 2020, by and among Eli Lilly and Company, Tyto Acquisition Corporation and Asa Abeliovich, M.D., Ph.D (Filed With SEC on December 15, 2020)
- Tender and Support Agreement, dated December 14, 2020, by and among Eli Lilly and Company, Tyto Acquisition Corporation, Pontifax (Cayman) V L.P., Pontifax (China) V L.P.,... (Filed With SEC on December 15, 2020)
- Open Market Sale AgreementSM dated as of August 11, 2020 by and between Prevail Therapeutics Inc. and Jefferies LLC (Filed With SEC on August 11, 2020)
- Description of Registrant's Securities (Filed With SEC on March 26, 2020)
- Offer letter, dated February 26, 2018, between Registrant and Franz Hefti, Ph.D (Filed With SEC on May 24, 2019)
- Offer letter, dated March 1, 2018, between Registrant and Jeffrey Sevigny, M.D (Filed With SEC on May 24, 2019)
- Offer letter, dated September 15, 2017, between Registrant and Asa Abeliovich, M.D., Ph.D (Filed With SEC on May 24, 2019)
- Form of Indemnity Agreement between Registrant and each of its directors and executive officers (Filed With SEC on May 24, 2019)
